Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
J Du, J Gu, J Li - Bioscience Reports, 2020 - portlandpress.com
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
[PDF][PDF] Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
J Du, J Gu, J Li - 2020 - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
J Du, J Gu, J Li - Bioscience Reports, 2020 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
J Du, J Gu, J Li - Bioscience Reports, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Pancreatic ductal adenocarcinoma (PDAC) is
the fourth leading cause of cancer-related death worldwide, and the mortality of patients with …
the fourth leading cause of cancer-related death worldwide, and the mortality of patients with …
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
J Du, J Gu, J Li - Bioscience Reports, 2020 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
J Du, J Gu, J Li - Bioscience reports, 2020 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
[HTML][HTML] Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
J Du, J Gu, J Li - Bioscience Reports, 2020 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
[PDF][PDF] Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
J Du, J Gu, J Li - 2020 - scholar.archive.org
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
J Du, J Gu, J Li - Bioscience Reports, 2020 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related
death worldwide, and the mortality of patients with PDAC has not significantly decreased …
death worldwide, and the mortality of patients with PDAC has not significantly decreased …